Want to join the conversation?
$RL 1Q16 Call: FY16 guidance: RL continues to expect mid-single-digit constant currency revenue growth. Retail segment revenues are expected to growth faster than Wholesale, and based on current exchange rates foreign currency will have about 450 BP negative impact on FY16 revenue growth.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.